l-NAME, an inhibitor of nitric oxide synthase, blocks the established allodynia induced by intrathecal administration of prostaglandin E2
- 1 December 1995
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 201 (3) , 239-242
- https://doi.org/10.1016/0304-3940(95)12176-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Nitric oxide mediates allodynia induced by intrathecal administration of prostaglandin E2 or prostaglandin F2α in conscious micePain, 1995
- Characterization of EP‐receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to miceBritish Journal of Pharmacology, 1994
- Involvement of glutamate receptors in allodynia induced by prostaglandins E 2 and F 2α injected into conscious micePain, 1994
- Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious micePain, 1994
- Systemic N-nitro-L-arginine-ester (L-NAM E), inhibitor of nitric oxide synthase, relieves chronic allodynia-like symptom in rats with spinal cord lesionActa Physiologica Scandinavica, 1994
- Hyperalgesia Mediated by Spinal Glutamate or Substance P Receptor Blocked by Spinal Cyclooxygenase InhibitionScience, 1992
- Nitric oxide, a novel neuronal messengerNeuron, 1992
- The excitatory amino acid receptor antagonist MK-801 prevents the hypersensitivity induced by spinal cord ischemia in the ratExperimental Neurology, 1991
- Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following c fibre stimulation.Neuropharmacology, 1987
- Intrathecal morphine in mice: A new techniqueEuropean Journal of Pharmacology, 1980